| PRD_000616 | Name: | 3-cyclohexyl-D-alanyl-L-prolyl-N~2~-methyl-L-arginine | Formula: | C21 H38 N6 O4 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000617 | Name: | (1S,7S)-7-amino-N-[(2R,3S)-7-amino-1-(cyclohexylamino)-2-hydroxy-1-oxoheptan-3-yl]-7-benzyl-8-oxohexahydro-1H-pyrazolo[1,2-a]pyridazine-1-carboxamide | Formula: | C28 H44 N6 O4 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000618 | Name: | (1S,7S)-7-amino-7-benzyl-N-[(1S)-4-carbamimidamido-1-{(1S)-1-hydroxy-2-oxo-2-[(2-phenylethyl)amino]ethyl}butyl]-8-oxohexahydro-1H-pyrazolo[1,2-a]pyridazine-1-carboxamide | Formula: | C30 H42 N8 O4 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000619 | Name: | (1S,7S)-7-amino-7-benzyl-N-{(1S)-4-carbamimidamido-1-[(S)-hydroxy(1,3-thiazol-2-yl)methyl]butyl}-8-oxohexahydro-1H-pyra
zolo[1,2-a]pyridazine-1-carboxamide | Formula: | C24 H34 N8 O3 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000621 | Name: | D-phenylalanyl-N-{(1S)-1-[(S)-1,3-benzothiazol-2-yl(hydroxy)methyl]-4-carbamimidamidobutyl}-L-prolinamide | Formula: | C27 H35 N7 O3 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000622 | Name: | amino{[(4S)-4-({[5-(dimethylamino)naphthalen-1-yl]sulfonyl}amino)-5-oxo-5-{(2R)-2-[3-oxo-3-(1,3-thiazol-2-yl)propyl]pip
eridin-1-yl}pentyl]amino}methaniminium | Formula: | C29 H40 N7 O4 S2 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000623 | Name: | N-methyl-D-phenylalanyl-N-{(1S)-4-carbamimidamido-1-[(6-carboxy-1,3-benzothiazol-2-yl)carbonyl]butyl}-L-prolinamide | Formula: | C29 H35 N7 O5 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000628 | Name: | [N-[N-(4-METHOXY-2,3,6-TRIMETHYLPHENYLSULFONYL)-L-ASPARTYL]-D-(4-AMIDINO-PHENYLALANYL)]-PIPERIDINE | Formula: | C29 H39 N5 O7 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000630 | Name: | N~2~-{(2R)-4-(methylamino)-4-oxo-2-[4-(phosphonooxy)benzyl]butanoyl}-L-glutaminyl-L-aspartamide | Formula: | C21 H31 N6 O10 P | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000632 | Name: | (1R,2S,3R,1S',1S")Phosphoric acid mono(4-{2-[1-(1,2-dicarbamoylethylcarbamoyl)-3-carbamoylpropylcarbamoyl]-3-methylcarbamoylcyclopropyl}phenyl) ester | Formula: | C22 H32 N5 O9 P | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000633 | Name: | N~2~-({(1R,2R,3S)-2-(methylcarbamoyl)-3-[4-(phosphonooxy)phenyl]cyclopropyl}carbonyl)-D-glutaminyl-D-aspartamide | Formula: | C21 H29 N6 O10 P | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000634 | Name: | N-{(2S)-4-(methylamino)-4-oxo-2-[4-(phosphonooxy)benzyl]butanoyl}-L-isoleucyl-L-aspartamide | Formula: | C22 H34 N5 O9 P | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000635 | Name: | N-{(2S)-4-(methylamino)-4-oxo-2-[4-(phosphonooxy)benzyl]butanoyl}-L-alpha-glutamyl-L-aspartamide | Formula: | C21 H30 N5 O11 P | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000638 | Name: | N-ALPHA-L-RHAMNOPYRANOSYLOXY(HYDROXYPHOSPHINYL)-L-LEUCYL-L-TRYPTOPHAN | Formula: | C23 H34 N3 O10 P | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000639 | Name: | 5,5,5-TRIFLUORO-3-HYDROXY-4-[2-(5,5,5-TRIFLUORO-3-HYDROXY-4-{3-METHYL-2-[3-METHYL-2-(3-METHYL-BUTYRYLAMINO)-BUTYRYLAMINO]-BUTYRYLAMINO}-PENTANOYLAMINO)-PROPIONYLAMINO]-PENTANOIC ACID METHYL ESTER | Formula: | C29 H47 F6 N5 O9 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000640 | Name: | 5,5,5-TRIFLUORO-3-HYDROXY-4-[2-(5,5,5-TRIFLUORO-3-HYDROXY-4-{3-METHYL-2-[3-METHYL-2-(3-METHYL-BUTYRYLAMINO)-BUTYRYLAMINO]-BUTYRYLAMINO}-PENTANOYLAMINO)-PROPIONYLAMINO]-PENTANOIC ACID | Formula: | C28 H45 F6 N5 O9 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000641 | Name: | (10R,20R,23R)-10-(4-aminobutyl)-1-[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]-20,23-bis(3-carbamimidamidopropyl)-1,8,11,18,21-pentaoxo-2,9,12,19,22-pentaazatetracosan-24-amide | Formula: | C40 H70 N18 O9 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
| PRD_000642 | Name: | (10R,20R,23R)-1-[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]-20,23-bis(3-carbamimidamido
propyl)-10-methyl-1,8,11,18,21-pentaoxo-2,9,12,19,22-pentaazatetracosan-24-amide | Formula: | C37 H63 N17 O9 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
| PRD_000645 | Name: | (2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-N-(6-{[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-carbamoylbutyl]carbamoyl}butyl]amino}-6-oxohexyl)-3,4-dihydroxytetrahydrofuran-2-carboxamide | Formula: | C28 H47 N15 O7 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
| PRD_000651 | Name: | N-[(S)-({[(benzyloxy)carbonyl]amino}methyl)(hydroxy)phosphoryl]-L-alanyl-L-leucine | Formula: | C18 H28 N3 O7 P | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000652 | Name: | N-[(S)-({[(benzyloxy)carbonyl]amino}methyl)(hydroxy)phosphoryl]-L-valyl-L-leucine | Formula: | C20 H32 N3 O7 P | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000653 | Name: | N-[(S)-({[(benzyloxy)carbonyl]amino}methyl)(hydroxy)phosphoryl]-L-phenylalanyl-L-leucine | Formula: | C24 H32 N3 O7 P | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000654 | Name: | N-[(S)-({[(benzyloxy)carbonyl]amino}methyl)(hydroxy)phosphoryl]-L-leucyl-L-leucine | Formula: | C21 H34 N3 O7 P | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000655 | Name: | N-[(2R,4S)-4-hydroxy-2-(2-methylpropyl)-4-oxido-7-oxo-9-phenyl-3,8-dioxa-6-aza-4-phosphanonan-1-oyl]-L-leucine | Formula: | C21 H33 N2 O8 P | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000656 | Name: | N-[(S)-[(1R)-1-{[(benzyloxy)carbonyl]amino}-2-phenylethyl](hydroxy)phosphoryl]-L-leucyl-L-alanine | Formula: | C25 H34 N3 O7 P | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|